PharmacoEconomics
Collection
Collection
- ISSN: 11707690
- https://link.springer.com/journal/40273
Published by ADI BV
-
Combination vaccine against invasive meningococcal B and pneumococcal infections: Potential epidemiological and economic impact in the Netherlands Article
PharmacoEconomics, 24(2), 141-153.J.M. Bos (Jasper), H.C. Rüumke (Hans), K. Welte (Karl), L. Spanjaard (Lodewijk), L. van Alphen (Loek) and M.J. Postma (Maarten)
February 2006
-
Productivity costs in health-state valuations: Does explicit instruction matter? Article
PharmacoEconomics, 24(4), 401-414.H.M. Krol (Marieke), W.B.F. Brouwer (Werner) and P.P. Sendi (Pedram)
April 2006
-
The use of disease-specific outcome measures in cost-utility analysis: The development of Dutch societal preference weights for the FACT-L scale Article
PharmacoEconomics, 25(7), 591-603.July 2007
-
A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease Article
PharmacoEconomics, 25(8), 695-711.M.P.M.H. Rutten-van Mölken (Maureen), F.E. van Nooten (Floortje), M. Lindemann (Marion), M. Caeser (Manfred) and P.M.A. Calverley
August 2007
-
The increasingly complex fourth hurdle for pharmaceuticals Review
J.P. Cohen (Joshua), E.A. Stolk (Elly) and M.G.H. Niezen (Maartje)
October 2007
-
The New Myth: The Social Value of the QALY Article
PharmacoEconomics, 26(1), 1-4.W.B.F. Brouwer (Werner), N.J.A. van Exel (Job), R.M. Baker (Rachel) and C.R. Donaldson (Cam)
January 2008 -
An overview of methods and applications to value informal care in economic evaluations of healthcare Article
PharmacoEconomics, 26(4), 269-280.M.A. Koopmanschap (Marc), N.J.A. van Exel (Job), B. van den Berg (Bernard) and W.B.F. Brouwer (Werner)
June 2008 -
An overview of methods and applications to value informal care in economic evaluations of healthcare Review
M.A. Koopmanschap (Marc), N.J.A. van Exel (Job), W.B.F. Brouwer (Werner) and B. van den Berg (Bernard)
June 2008